<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36293534</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>20</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12676</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232012676</ELocationID><Abstract><AbstractText>Mitophagy is the selective degradation of mitochondria by autophagy. It promotes the turnover of mitochondria and prevents the accumulation of dysfunctional mitochondria, which can lead to cellular degeneration. Mitophagy is known to be altered in several pathological conditions, especially in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). We recently demonstrated an increase in autophagy flux in lymphoblasts from ALS patients bearing a mutation in SOD1. Thus, the identification of mitophagy inhibitors may be a therapeutic option to recover mitochondrial homeostasis. Here, using a phenotypic mitophagy assay, we identified a new mitophagy inhibitor, the small molecule named IGS2.7 from the MBC library. Interestingly, the treatment of different cellular and in vivo models of ALS with mutations on SOD1 and <i>TARDBP</i> with this inhibitor restores autophagy to control levels. These results point mitophagy inhibitors, especially IGS2.7, to a new therapeutic approach for familial ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maestro</LastName><ForeName>Ines</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5026-5803</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Biol&#xf3;gicas Margarita Salas-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Ballina</LastName><ForeName>Laura R</ForeName><Initials>LR</Initials><Identifier Source="ORCID">0000-0001-5363-7433</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porras</LastName><ForeName>Gracia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centro de Investigaciones Biol&#xf3;gicas Margarita Salas-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrochano</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0958-0083</Identifier><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico San Carlos, Instituto de Investigaci&#xf3;n Sanitaria San Carlos, Calle del Prof Mart&#xed;n Lagos s/n, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Lago</LastName><ForeName>Eva</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6260-3777</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Universitario de Investigaci&#xf3;n en Neuroqu&#xed;mica, Departamento de Bioqu&#xed;mica y Biolog&#xed;a Molecular, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto Ram&#xf3;n y Cajal de Investigaci&#xf3;n Sanitaria (IRYCIS), 28034 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonsen</LastName><ForeName>Anne</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4711-7057</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boya</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3045-951X</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Biol&#xf3;gicas Margarita Salas-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2707-8110</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Biol&#xf3;gicas Margarita Salas-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28031 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>H2020-MSCA-ITN-2017 (grant no. 765912, DRIVE project)</GrantID><Agency>European Commission</Agency><Country/></Grant><Grant><GrantID>B2017/BMD-3813</GrantID><Agency>Comunidad de Madrid</Agency><Country/></Grant><Grant><GrantID>CB18/05/00040</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>Interdisciplinary Thematic Platform (PTI+) NEURO-AGINGl+</GrantID><Agency>Spanish National Research Council</Agency><Country/></Grant><Grant><GrantID>Fondos de recuperaci&#xf3;n</GrantID><Agency>European Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="Y">Mitophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">drug discovery</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword><Keyword MajorTopicYN="N">phenotypic assay</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36293534</ArticleId><ArticleId IdType="pmc">PMC9603920</ArticleId><ArticleId IdType="doi">10.3390/ijms232012676</ArticleId><ArticleId IdType="pii">ijms232012676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S., Panigrahi D.P., Patil S., Bhutia S.K. Autophagy in health and disease: A comprehensive review. Biomed. Pharm. 2018;104:485&#x2013;495. doi: 10.1016/j.biopha.2018.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.05.007</ArticleId><ArticleId IdType="pubmed">29800913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Liu N., Lu B. Mechanisms and roles of mitophagy in neurodegenerative diseases. CNS Neurosci. Ther. 2019;25:859&#x2013;875. doi: 10.1111/cns.13140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13140</ArticleId><ArticleId IdType="pmc">PMC6566062</ArticleId><ArticleId IdType="pubmed">31050206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Kroemer G., Kepp O. Mitophagy: An Emerging Role in Aging and Age-Associated Diseases. Front. Cell Dev. Biol. 2020;8:200. doi: 10.3389/fcell.2020.00200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00200</ArticleId><ArticleId IdType="pmc">PMC7113588</ArticleId><ArticleId IdType="pubmed">32274386</ArticleId></ArticleIdList></Reference><Reference><Citation>Madruga E., Maestro I., Martinez A. Mitophagy Modulation, a New Player in the Race against ALS. Int. J. Mol. Sci. 2021;22:740. doi: 10.3390/ijms22020740.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020740</ArticleId><ArticleId IdType="pmc">PMC7828440</ArticleId><ArticleId IdType="pubmed">33450997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay U., Nagy M., Fenton W.A., Horwich A.L. Absence of lipofuscin in motor neurons of SOD1-linked ALS mice. Proc. Natl. Acad. Sci. USA. 2014;111:11055&#x2013;11060. doi: 10.1073/pnas.1409314111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1409314111</ArticleId><ArticleId IdType="pmc">PMC4121794</ArticleId><ArticleId IdType="pubmed">25024188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D.K.H., Thombre R., Wang J. Autophagy as a common pathway in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;697:34&#x2013;48. doi: 10.1016/j.neulet.2018.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhou B., Lin M.Y., Wang S., Foust K.D., Sheng Z.H. Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice. Neuron. 2015;87:355&#x2013;370. doi: 10.1016/j.neuron.2015.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.06.026</ArticleId><ArticleId IdType="pmc">PMC4511489</ArticleId><ArticleId IdType="pubmed">26182418</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicencio E., Beltran S., Labrador L., Manque P., Nassif M., Woehlbier U. Implications of Selective Autophagy Dysfunction for ALS Pathology. Cells. 2020;9:381. doi: 10.3390/cells9020381.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020381</ArticleId><ArticleId IdType="pmc">PMC7072226</ArticleId><ArticleId IdType="pubmed">32046060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lastres-Becker I., Porras G., Arribas-Blazquez M., Maestro I., Borrego-Hernandez D., Boya P., Cerdan S., Garcia-Redondo A., Martinez A., Martin-Requero A. Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy. Int. J. Mol. Sci. 2021;22:3007. doi: 10.3390/ijms22063007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063007</ArticleId><ArticleId IdType="pmc">PMC8000750</ArticleId><ArticleId IdType="pubmed">33809456</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastian-Perez V., Roca C., Awale M., Reymond J.L., Martinez A., Gil C., Campillo N.E. Medicinal and Biological Chemistry (MBC) Library: An Efficient Source of New Hits. J. Chem. Inf. Model. 2017;57:2143&#x2013;2151. doi: 10.1021/acs.jcim.7b00401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.7b00401</ArticleId><ArticleId IdType="pubmed">28813151</ArticleId></ArticleIdList></Reference><Reference><Citation>Princely Abudu Y., Pankiv S., Mathai B.J., Hakon Lystad A., Bindesboll C., Brenne H.B., Yoke Wui Ng M., Thiede B., Yamamoto A., Mutugi Nthiga T., et al. NIPSNAP1 and NIPSNAP2 Act as &#x201c;Eat Me&#x201d; Signals for Mitophagy. Dev. Cell. 2019;49:509&#x2013;525.e12. doi: 10.1016/j.devcel.2019.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2019.03.013</ArticleId><ArticleId IdType="pubmed">30982665</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen G.F., Toth R., James J., Ganley I.G. Loss of iron triggers PINK1/Parkin-independent mitophagy. EMBO Rep. 2013;14:1127&#x2013;1135. doi: 10.1038/embor.2013.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2013.168</ArticleId><ArticleId IdType="pmc">PMC3981094</ArticleId><ArticleId IdType="pubmed">24176932</ArticleId></ArticleIdList></Reference><Reference><Citation>Munson M.J., Mathai B.J., Ng M.Y.W., Trachsel-Moncho L., de la Ballina L.R., Schultz S.W., Aman Y., Lystad A.H., Singh S., Singh S., et al. GAK and PRKCD are positive regulators of PRKN-independent mitophagy. Nat. Commun. 2021;12:6101. doi: 10.1038/s41467-021-26331-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26331-7</ArticleId><ArticleId IdType="pmc">PMC8528926</ArticleId><ArticleId IdType="pubmed">34671015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hider R.C., Hoffbrand A.V. The Role of Deferiprone in Iron Chelation. N. Engl. J. Med. 2018;379:2140&#x2013;2150. doi: 10.1056/NEJMra1800219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1800219</ArticleId><ArticleId IdType="pubmed">30485781</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008;183:795&#x2013;803. doi: 10.1083/jcb.200809125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200809125</ArticleId><ArticleId IdType="pmc">PMC2592826</ArticleId><ArticleId IdType="pubmed">19029340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimori T., Yamamoto A., Moriyama Y., Futai M., Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 1991;266:17707&#x2013;17712. doi: 10.1016/S0021-9258(19)47429-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)47429-2</ArticleId><ArticleId IdType="pubmed">1832676</ArticleId></ArticleIdList></Reference><Reference><Citation>Salado I.G., Redondo M., Bello M.L., Perez C., Liachko N.F., Kraemer B.C., Miguel L., Lecourtois M., Gil C., Martinez A., et al. Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. J. Med. Chem. 2014;57:2755&#x2013;2772. doi: 10.1021/jm500065f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm500065f</ArticleId><ArticleId IdType="pmc">PMC3969104</ArticleId><ArticleId IdType="pubmed">24592867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F., Nonaka T., Suzuki T., Arai T., Dohmae N., Akiyama H., Hasegawa M. Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem. Biophys. Res. Commun. 2009;382:405&#x2013;409. doi: 10.1016/j.bbrc.2009.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.03.038</ArticleId><ArticleId IdType="pubmed">19285963</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachari M., Ganley I.G. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017;61:585&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869855</ArticleId><ArticleId IdType="pubmed">29233870</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Gonzalez L., Rodriguez-Cueto C., Cabezudo D., Bartolome F., Andres-Benito P., Ferrer I., Gil C., Martin-Requero A., Fernandez-Ruiz J., Martinez A., et al. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1delta kinase inhibitor treatment. Sci. Rep. 2020;10:4449. doi: 10.1038/s41598-020-61265-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-61265-y</ArticleId><ArticleId IdType="pmc">PMC7064575</ArticleId><ArticleId IdType="pubmed">32157143</ArticleId></ArticleIdList></Reference><Reference><Citation>Posa D., Martinez-Gonzalez L., Bartolome F., Nagaraj S., Porras G., Martinez A., Martin-Requero A. Recapitulation of pathological TDP-43 features in immortalized lymphocytes from sporadic ALS patients. Mol. Neurobiol. 2019;56:2424&#x2013;2432. doi: 10.1007/s12035-018-1249-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1249-8</ArticleId><ArticleId IdType="pubmed">30030753</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J., Abdel-Aziz A.K., Abdelfatah S., Abdellatif M., Abdoli A., Abel S., Abeliovich H., Abildgaard M.H., Abudu Y.P., Acevedo-Arozena A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1) Autophagy. 2021;17:1&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996087</ArticleId><ArticleId IdType="pubmed">33634751</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquezar C., Salado I.G., de la Encarnacion A., Perez D.I., Moreno F., Gil C., de Munain A.L., Martinez A., Martin-Requero A. Targeting TDP-43 phosphorylation by Casein Kinase-1delta inhibitors: A novel strategy for the treatment of frontotemporal dementia. Mol. Neurodegener. 2016;11:36. doi: 10.1186/s13024-016-0102-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0102-7</ArticleId><ArticleId IdType="pmc">PMC4852436</ArticleId><ArticleId IdType="pubmed">27138926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocak M., Ezazi Erdi S., Jorba G., Maestro I., Farres J., Kirkin V., Martinez A., Pless O. Targeting autophagy in disease: Established and new strategies. Autophagy. 2022;18:473&#x2013;495. doi: 10.1080/15548627.2021.1936359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1936359</ArticleId><ArticleId IdType="pmc">PMC9037468</ArticleId><ArticleId IdType="pubmed">34241570</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Guo Y., Wang X., Yu X., Duan W., Hong K., Wang J., Han H., Li C. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience. 2015;298:12&#x2013;25. doi: 10.1016/j.neuroscience.2015.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.03.061</ArticleId><ArticleId IdType="pubmed">25841320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q.M., Zhang J.J., Li S., Chen S., Le W.D. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. CNS Neurosci. Ther. 2017;23:375&#x2013;385. doi: 10.1111/cns.12681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12681</ArticleId><ArticleId IdType="pmc">PMC6492644</ArticleId><ArticleId IdType="pubmed">28229532</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestro I., de la Ballina L.R., Simonsen A., Boya P., Martinez A. Phenotypic Assay Leads to Discovery of Mitophagy Inducers with Therapeutic Potential for Parkinson&#x2019;s Disease. ACS Chem. Neurosci. 2021;12:4512&#x2013;4523. doi: 10.1021/acschemneuro.1c00529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00529</ArticleId><ArticleId IdType="pubmed">34846852</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo V., Nozal V., Rojas-Prats E., Gil C., Martinez A. Protein kinase inhibitors for amyotrophic lateral sclerosis therapy. Br. J. Pharmacol. 2021;178:1316&#x2013;1335. doi: 10.1111/bph.15221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15221</ArticleId><ArticleId IdType="pubmed">32737989</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Chen X., Xiong Q., Chen Y., Zhao H., Tahir M., Song J., Zhou B., Wang J. Casein Kinase 1 Family Member CK1delta/Hrr25 Is Required for Autophagosome Completion. Front. Cell Dev. Biol. 2020;8:460. doi: 10.3389/fcell.2020.00460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00460</ArticleId><ArticleId IdType="pmc">PMC7381346</ArticleId><ArticleId IdType="pubmed">32775325</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii S.R., Mizushima N. Monitoring and Measuring Autophagy. Int J Mol Sci. 2017;18:1865. doi: 10.3390/ijms18091865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091865</ArticleId><ArticleId IdType="pmc">PMC5618514</ArticleId><ArticleId IdType="pubmed">28846632</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban-Martinez L., Sierra-Filardi E., McGreal R.S., Salazar-Roa M., Marino G., Seco E., Durand S., Enot D., Grana O., Malumbres M., et al. Programmed mitophagy is essential for the glycolytic switch during cell differentiation. EMBO J. 2017;36:1688&#x2013;1706. doi: 10.15252/embj.201695916.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695916</ArticleId><ArticleId IdType="pmc">PMC5470043</ArticleId><ArticleId IdType="pubmed">28465321</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech E., Maestre C., Esteban-Martinez L., Partida D., Pascual R., Fernandez-Miranda G., Seco E., Campos-Olivas R., Perez M., Megias D., et al. AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest. Nat. Cell Biol. 2015;17:1304&#x2013;1316. doi: 10.1038/ncb3231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3231</ArticleId><ArticleId IdType="pubmed">26322680</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliams T.G., Prescott A.R., Allen G.F., Tamjar J., Munson M.J., Thomson C., Muqit M.M., Ganley I.G. mito-QC illuminates mitophagy and mitochondrial architecture in vivo. J. Cell Biol. 2016;214:333&#x2013;345. doi: 10.1083/jcb.201603039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201603039</ArticleId><ArticleId IdType="pmc">PMC4970326</ArticleId><ArticleId IdType="pubmed">27458135</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 4 March 2022)].  Available online:  https://www.proteinatlas.org/ENSG00000185345-PRKN/tissue.</Citation></Reference><Reference><Citation>Martinez-Vicente M. Neuronal Mitophagy in Neurodegenerative Diseases. Front. Mol. Neurosci. 2017;10:64. doi: 10.3389/fnmol.2017.00064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00064</ArticleId><ArticleId IdType="pmc">PMC5340781</ArticleId><ArticleId IdType="pubmed">28337125</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Al-Chalabi A., Filippi M., Hardiman O., Kaji R., Meininger V., Nakano I., Shaw P., Shefner J., van den Berg L.H., et al. The El Escorial criteria: Strengths and weaknesses. Amyotroph. Lateral Scler. Front. Degener. 2015;16:1&#x2013;7. doi: 10.3109/21678421.2014.964258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.964258</ArticleId><ArticleId IdType="pubmed">25482030</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., Guertin D.A., Chang J.H., Lindquist R.A., Moffat J., et al. CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100. doi: 10.1186/gb-2006-7-10-r100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2006-7-10-r100</ArticleId><ArticleId IdType="pmc">PMC1794559</ArticleId><ArticleId IdType="pubmed">17076895</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>